Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    

| More

White Goods - Q1FY21 does not provide any discernible business trend - ICICI Securities

Posted On: 2020-07-29 22:13:34

Q1FY21 should not have any bearing on the business expectations in a steady state situation considering the unique impact of nationwide lockdown which will continue albeit in an intermittent manner in Q2FY21 as well. We highlight key trends which have come up from the results of Crompton Consumer (Crompton), Havells and V-Guard (VGRD).

- Q1FY21 is a one-off quarter with little bearing on normalised business growth. All three consumer electrical companies (Havells, VGRD and Crompton) have reported ~45% revenue drop in Q1FY21. April has witnessed complete shutdown with gradual restoration to ~70% levels in May and 90-105% growth YoY in June. However, the proportion of business decline is more due to higher sales share of April. Additionally, due to pent up demand, the revenue trajectory has been decided more by the level of business normalcy rather than execution. Common trends include more demand of B2C compared to B2B products, better sales in non-metro regions and relative inelasticity of price as sales have been driven by more of a push rather than sales. Havells has reported market share gain from unorganised players who were impacted from supply-chain disruption.

- Can we rank performance by gross margin show? With little control over revenue (more a factor business normalcy), it can be argued that gross margin is a better measure of successful adaptation of companies to the unique situation posed by Covid-19 outbreak. Crompton (flat gross margins YoY) has fared better than Havells/VGRD (280/340 bps drop in YoY gross margins). This could have been aided by higher share of outsourcing in the manufacturing mix of Crompton.

- Recovery to normalcy will be non-linear; July will mostly lag June. The business normalcy and the subsequent recovery will depend on the extent of the impact from Covid-19 outbreak. Most companies have prepared themselves against covid-19 related uncertainties by building up strong balance sheet (Q1FY21 net cash position for Havells/Crompton/V-Guard stands at Rs8.4/4.5bn/Rs3.5bn)

- Maintain ADD on Havells and Crompton, HOLD on VGRD. We expect 4.5%/23.4% revenue/PAT decline for Havells with EBITDA margin of 10.5% in FY21. And 24%/69% revenue/PAT growth with EBITDA margin of 13.2% in 22E, respectively. Havells continues to possess an additional lever for outperformance depending upon the performance of Lloyds which will have tailwinds of in-house manufacturing in FY21/22. We expect 12/23% revenue/PAT decline for Crompton with EBITDA margin of 12.5% in FY21/ and 27.2/35.4% revenue/PAT growth with EBITDA margin of 13.3% in 22E, respectively. The higher share of B2C mix and relative stability in LED price trends set up Crompton for a fast turnaround as and when there is recovery from Covid-19 pandemic. The growth in appliances (.Appliances grew by 60% in Jan/Feb led by geysers (97%), mixer grinders (54%) and coolers (86%)) is slowly showing promise. VGRD has relatively outperformed peers (15% EBITDA change in FY20 compared to -12.8%/+2.5% for Havells/Crompton). Higher dependence on summers (stabilisers, fans) and lower margins especially in non-south markets are headwinds.

Source: Equity Bulls

Click here to send ur comments or to

Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only., its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.

Other Headlines:

IPO Review - Computer Age Management Services - ICICI Securities

Company Update - EIH Ltd - ICICI Securities

Gladiator Stocks - Godrej Properties - ICICI Securities

Company Update - Dr Reddy's Laboratories - ICICI Securities

Gladiator Stocks: Pharma Thematic - ICICI Securities

Company Update - Housing & Urban Development - ICICI Securities

Covid Recovery Pulse - E-Way bill generation shows recovery signs with auto volumes flat - ICICI Securities

Quant Pick - UltraTech Cement - ICICI Securities

Lupin & Cipla - Positive News - Angel Broking

Sterling and Wilson Solar Ltd - 106.71 MW order win - Angel Broking

Dr. Reddy's Laboratories - Settles Revlimid litigation in US - ICICI Securities

Natco Pharma - Natco to launch first generic Revlimid - ICICI Securities

Solar Industries - Overseas and defence key to profitability - ICICI Securities

Federal Bank - Strengthening liability muscle; fees & charges revised upwards - ICICI Securities

HCL Technologies Mr. Jyoti Roy, DVP - Equity Strategist, Angel Broking Ltd


I-direct Instinct - Intellect Design Arena

P&G Health - Company Update - ICICI Securities

Relaxo Footwears - Mr. Amarjeet Maurya- AVP - Mid Caps, Angel Broking Ltd

Bata India - Mr. Amarjeet Maurya- AVP - Mid Caps, Angel Broking Ltd

Listing of Happiest Minds Technologies - Angel Broking

Dr. Reddy's Lab - Sep 17, 2020 - Angel Broking

VA Tech Wabag - Uphill task ahead; dilution at discount valuation - ICICI Securities

Polymer price tracker - PVC price hikes continue unabated - ICICI Securities

Brigade Enterprises - Resilience amid turbulence - ICICI Securities

Apollo Hospitals Enterprises - Recovering well from COVID-19 impact - ICICI Securities

NTPC - Sustainability targets encouraging - ICICI Securities

Gladiator Stocks - Oberoi Realty - ICICI Securities

Gladiator Stocks - Automotive Axles - ICICI Securities

Quant Pick - IDFC First Bank - ICICI Securities

Company Update - Jammu & Kashmir Bank - ICICI Securities

India Aviation Data - August 2020 - Angel Broking

Shree Cement - Higher volumes to offset lower prices - ICICI Securities

Apollo Hospitals - Q1FY21 Result Update - ICICI Securities

Refining & marketing - Oil price fall boosted GRMs, to push marketing margins up - ICICI Securities

Mr. Deepak Jasani, Head of Retail Research views on FICCI National Executive Committee Meeting with Reserve Bank of India Governor Shaktikanta Das

India trade deficit for August 2020 - Angel Broking

Chemcon Chemicals IPO - Mr. Keshav Lahoti - Associate Equity Analyst, Angel Broking Ltd

CAMS IPO - Mr. Jaikishan Parmar - Sr. Equity Research Analyst, Angel Broking Ltd

August 2020 Trade Data - Acuité Ratings & Research

Wim Plast - Q1FY21 Result Update - ICICI Securities

Company Update - Mishra Dhatu Nigam - ICICI Securities

Stock Tales - Laurus Labs - ICICI Securities

Stock Tales - Granules India - ICICI Securities

Stock of the day - Chalet Hotel - Target INR 200 - Angel Broking

Upgrade to ADD on Dr. Reddy's Labs - Improved visibility in the US business - HDFC Securities

Monetary Policy post CPI inflation numbers for August 2020 - Angel Broking

HUDCO - Q1FY21 Result Update - Angel Broking

Update on Steriscience pharma - Angel Broking

Covid-19 vaccine development by AstraZeneca - Angel Broking

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019